Literature DB >> 18995876

The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein.

Mindy Gore1, Lindsey M Hutt-Fletcher.   

Abstract

Epstein-Barr virus has been documented to encode for ten envelope glycoproteins, gB, gH, gL, gM, gN, gp350, gp42, gp78, gp150 and BMRF2. The BDLF2 open reading frame is also predicted to encode a type II membrane protein but, although found in the virion, it has been described as a component of the tegument. We show here that, as predicted, it is the eleventh envelope glycoprotein of the virus. The full length 65 kDa glycoprotein formed a complex with BMRF2 and, as its homologs in other gammaherpesviruses, was dependent on BMRF2, for authentic processing and transport. Two cleavage products of BDLF2 were also identified in cells and in purified virion particles, one corresponding approximately to the aminoterminal half of the protein, that remained associated with the full length form, and one corresponding to the carboxyterminal glycosylated portion of the protein which did not.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18995876      PMCID: PMC2630507          DOI: 10.1016/j.virol.2008.10.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.

Authors:  T Oda; S Imai; S Chiba; K Takada
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

2.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

3.  Proteins of purified Epstein-Barr virus.

Authors:  Eric Johannsen; Micah Luftig; Michael R Chase; Steve Weicksel; Ellen Cahir-McFarland; Diego Illanes; David Sarracino; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

4.  Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion.

Authors:  Liguo Wu; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2007-02-20       Impact factor: 3.616

5.  Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.

Authors:  S J Molesworth; C M Lake; C M Borza; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Characterization of the Epstein-Barr virus glycoprotein BMRF-2.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Sharof M Tugizov
Journal:  Virology       Date:  2006-11-01       Impact factor: 3.616

7.  The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Jennifer Berline; Sharof M Tugizov
Journal:  Virology       Date:  2007-10-22       Impact factor: 3.616

8.  The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread.

Authors:  Janet S May; Jennifer Walker; Susanna Colaco; Philip G Stevenson
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport.

Authors:  Janet S May; Brigitte D de Lima; Susanna Colaco; Philip G Stevenson
Journal:  Traffic       Date:  2005-09       Impact factor: 6.215

10.  A gamma-herpesvirus glycoprotein complex manipulates actin to promote viral spread.

Authors:  Michael B Gill; Rachel Edgar; Janet S May; Philip G Stevenson
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more
  10 in total

1.  Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Authors:  Gabriela M Escalante; Lorraine Z Mutsvunguma; Murali Muniraju; Esther Rodriguez; Javier Gordon Ogembo
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

2.  EBV-positive human sera contain antibodies against the EBV BMRF-2 protein.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Carl Sunshine; Sharof M Tugizov
Journal:  Virology       Date:  2009-08-20       Impact factor: 3.616

3.  The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.

Authors:  Liudmila S Chesnokova; Sarah M Valencia; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2016-04-08       Impact factor: 3.616

4.  Epstein-Barr virus glycoprotein gM can interact with the cellular protein p32 and knockdown of p32 impairs virus.

Authors:  Harish Changotra; Susan M Turk; Antonio Artigues; Nagendra Thakur; Mindy Gore; Martin I Muggeridge; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2016-01-13       Impact factor: 3.616

5.  EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Jennifer Berline; Sharof M Tugizov
Journal:  Virology       Date:  2009-04-24       Impact factor: 3.616

6.  EBV glycoproteins: where are we now?

Authors:  Lindsey M Hutt-Fletcher
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

7.  Global aspects of viral glycosylation.

Authors:  Ieva Bagdonaite; Hans H Wandall
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

8.  An RS motif within the Epstein-Barr virus BLRF2 tegument protein is phosphorylated by SRPK2 and is important for viral replication.

Authors:  Melissa Duarte; Lili Wang; Michael A Calderwood; Guillaume Adelmant; Makoto Ohashi; Jennifer Roecklein-Canfield; Jarrod A Marto; David E Hill; Hongyu Deng; Eric Johannsen
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

9.  A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.

Authors:  Ina Ersing; Luis Nobre; Liang Wei Wang; Lior Soday; Yijie Ma; Joao A Paulo; Yohei Narita; Camille W Ashbaugh; Chang Jiang; Nicholas E Grayson; Elliott Kieff; Steven P Gygi; Michael P Weekes; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

10.  Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus.

Authors:  Fisayo A Olotu; Mahmoud E S Soliman
Journal:  Biomed J       Date:  2021-06-19       Impact factor: 4.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.